8-KEarnings & ResultsExhibits & Filings

CVS HEALTH Corp 8-K Report, Financial Results (May 5, 2011)

Filed May 5, 2011For Securities:CVS

Summary

CVS Health Corporation (then CVS Caremark Corporation) filed an 8-K on May 5, 2011, to report its financial results for the first quarter ended March 31, 2011. The filing primarily serves to attach the company's earnings press release, which provides detailed operational and financial condition updates for the period. Investors should refer to the press release, attached as Exhibit 99.1, for the specific financial figures and management's commentary. This report does not contain new material information beyond what is disclosed in the press release. The key takeaway for investors is that this 8-K acts as a formal notification of the release of quarterly earnings and directs them to the accompanying press release for the substantive financial data. The filing also confirms the Chief Financial Officer, David M. Denton, signed off on the report.

Key Highlights

  • 1CVS Health (CVS) filed an 8-K on May 5, 2011, to report its Q1 2011 earnings.
  • 2The filing's primary purpose is to attach the earnings press release (Exhibit 99.1).
  • 3This report does not contain new material information beyond the press release.
  • 4Investors should consult the May 5, 2011, press release for detailed Q1 2011 financial results and commentary.
  • 5The filing confirms the date of the earliest event reported as May 5, 2011.
  • 6David M. Denton, Executive Vice President and Chief Financial Officer, signed the report.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report CVS Health Corporation's earnings for the first quarter ended March 31, 2011, by attaching the corresponding press release as an exhibit.

The detailed financial results and management's commentary for the first quarter ended March 31, 2011, can be found in the press release dated May 5, 2011, which is included as Exhibit 99.1 to this 8-K filing.

No, this 8-K filing primarily serves to attach the company's earnings press release. Any substantive financial or operational details will be within that press release, and the 8-K itself does not introduce new material information beyond directing investors to that document.

This report was signed by David M. Denton, who was the Executive Vice President and Chief Financial Officer of CVS Caremark Corporation at the time.